Glenn N. Langton
About Glenn N. Langton
Glenn N. Langton is a Senior Manufacturing Engineer at Inari Medical, where he has worked since 2022. He has extensive experience in medical device production and engineering, having previously held positions at NuSil Technology LLC, Trelleborg Sealing Solutions, and Iconoglyph.
Work at Inari Medical
Glenn N. Langton has been employed as a Senior Manufacturing Engineer at Inari Medical since 2022. He is based in Irvine, California, where he contributes to the development and improvement of manufacturing processes for medical devices. His role involves implementing innovative production methods that enhance cost efficiency and product quality.
Previous Experience
Before joining Inari Medical, Langton held several engineering positions. He worked at NuSil Technology LLC as a Project Engineer from 2010 to 2015, focusing on medical device production. He also served as a Senior Manufacturing Engineer at Trelleborg Sealing Solutions from 2015 to 2022, where he led projects that transitioned medical devices from research and development to market release. Additionally, he was a Consumer Product Development Consultant at Iconoglyph from 2011 to 2022.
Education and Expertise
Langton studied at the University of California, Davis, where he earned a Bachelor of Science degree in Aeronautical Engineering. He also holds a Bachelor of Science degree in Mechanical Engineering from the same institution. His educational background provides a strong foundation for his expertise in manufacturing engineering and product development.
Achievements in Manufacturing Engineering
Throughout his career, Langton has developed innovative methods for medical device production, resulting in cost savings and quality improvements for clients. He led a company excellence program that achieved approximately 3% savings in cost of goods sold annually through continuous improvement initiatives. He also designed specialized equipment for silicone breast implant production and developed a pilot manufacturing line for a glaucoma stent, which generated over $8 million in annual sales.